SCHEMBL1776018

SCHEMBL1776018

[CH2]N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.55
ALDH1A1 P00352 2/20 0.55
AOC3 Q16853 1/20 0.50
CALM1 P0DP23 1/20 0.45
CA2 P00918 1/20 0.44
CARM1 Q86X55 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
PRMT8 Q9NR22 1/20 0.43
CYP2C19 P33261 1/20 0.43
MGLL Q99685 1/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2A P28223 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRK1 P41145 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1535594 0.85 TSHR (0.54) TSHRALDH1A1AOC3CARM1PRMT6
SCHEMBL294642 0.83 TSHR (0.64) TSHRALDH1A1AOC3CA2CARM1
SCHEMBL5462064 0.82 TSHR (0.55) TSHRALDH1A1AOC3CALM1CA2
SCHEMBL4397375 0.81 GAA (0.44) TSHRALDH1A1AOC3CA2MGLL
SCHEMBL3374460 0.81 TSHR (0.48) TSHRALDH1A1AOC3CARM1PRMT6
SCHEMBL5943982 0.81 HTT (0.46) TSHRALDH1A1AOC3CARM1PRMT6
SCHEMBL10840009 0.78 AOC3 (0.58) TSHRALDH1A1AOC3CALM1CA2
SCHEMBL10842660 0.78 TSHR (0.50) TSHRALDH1A1AOC3CA2CYP2C19
SCHEMBL3371050 0.78 TSHR (0.45) TSHRALDH1A1AOC3OPRK1KCNH2
SCHEMBL7248276 0.76 TSHR (0.50) TSHRALDH1A1AOC3CALM1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943605-B2 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses UCB PHARMA S.A. (BE) 2011-05-17 US claimed
EP-1673349-B1 BENZIMIDAZOLE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S BIO PTE LTD (SG) 2010-06-30 EP claimed
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 US claimed
CN-101296902-A Compounds comprising lactam or lactam derivative moieties, processes for preparing them and their use UCB PHARMA SA (BE) 2008-10-29 CN claimed
EP-1943217-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2008-07-16 EP claimed
EP-1673349-A4 BENZIMIDAZOLE DERIVATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S BIO PTE LTD (SG) 2008-01-23 EP claimed
WO-2007048595-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA, S.A. (BE) 2007-05-03 WO claimed
JP-2007505942-A 2007-03-15 JP claimed
US-20070043043-A1 Benzimidazole derivates: preparation and pharmaceutical applications S*BIO PTE LTD. (SG) 2007-02-22 US claimed
EP-1673349-A1 BENZIMIDAZOLE DERIVATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*Bio Pte Ltd (SG) 2006-06-28 EP claimed
WO-2005028447-A1 BENZIMIDAZOLE DERIVATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*BIO PTE LTD (SG) 2005-03-31 WO claimed
EP-1074544-B1 Process for production of 3-(3-pyridyl)-1-propanol derivatives KANEKA CORP (JP) 2003-08-27 EP claimed
US-6586644-B2 Reacting aldehyde compound and terminal acetylene in presence of optically active amino alcohol, using tertiary amine and zinc halogenated lower alkane sulfonate as catalyst Carreira, Erick M. (CH) 2003-07-01 US claimed
US-20030088100-A1 Process for producing optically active propargyl alcohols SUMIKA FINE CHEMICALS CO., LTD. 2003-05-08 US claimed
EP-1095043-A1 TRIOXANE DERIVATIVES The Hong Kong University of Science & Technology (HK) 2001-05-02 EP claimed
WO-2000004026-A1 TRIOXANE DERIVATIVES THE HONG KONG UNIVERSITY OF SCIENCE & TECHNOLOGY (CN) 2000-01-27 WO claimed
EP-3864002-B1 ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-12-27 EP disclosed
WO-2023101004-A1 OLEFIN RESIN, METHOD FOR MANUFACTURING SAME, AND APPLICATION FOR SAME 三井化学株式会社 2023-06-08 WO disclosed
US-4427753-A Electrophotographic photosensitive member with disazo or trisazo compound CANON KABUSHIKI KAISHA (JP) 1984-01-24 US disclosed
US-4418133-A Disazo photoconductive material and electrophotographic photosensitive member having disazo pigment layer CANON KABUSHIKI KAISHA (JP) 1983-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043043-A1 Benzimidazole derivates: preparation and pharmaceutical applications HDAC5, HDAC1, HDAC4 TSHR 3393/4885ALDH1A1 305/4885AOC3 3191/4885
US-20030088100-A1 Process for producing optically active propargyl alcohols ADH1A, ADH1C, ADH5 TSHR 53/4885ALDH1A1 27/4885AOC3 59/4885
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses COASY, FURIN, PEPD TSHR 4554/4885ALDH1A1 1149/4885AOC3 3344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.